Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Incorporating prognostic information into treatment decisions in chronic lymphocytic leukemia.

Current oncology reports - 1 Sept 2009

Jain Nitin, Lamanna Nicole

Abstract excerpt

Most patients with chronic lymphocytic leukemia are diagnosed at an early stage, when traditional staging systems fail to distinguish those with an aggressive disease course from those with an excellent prognosis. This failure underscores the need for better prognostic markers. Although many mark...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ADP-ribosyl Cyclase 1
Share to Biomarkers, Tumor
Share to Chromosome Aberrations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoglobulin Heavy Chains

Share to Immunoglobulin Variable Region

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Prognosis

Share to ZAP-70 Protein-Tyrosine Kinase

Source

Identifiers

PMID: 19679010
DOI: 10.1007/s11912-009-0048-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19679010-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Incorporating prognostic information into treatment decisions in chronic lymphocytic leukemia.PMID 19679010Read ↗

Prognostic factors and risk stratification in chronic lymphocytic leukemia.Semantic proximity Read ↗

Can prognostic factors be used to direct therapy in chronic lymphocytic leukemia?Semantic proximity Read ↗

Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemiaSemantic proximity Read ↗

Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?Semantic proximity Read ↗

Defining the prognosis of early stage chronic lymphocytic leukaemia patients.Semantic proximity Read ↗

Clinical prognostic biomarkers in chronic lymphocytic leukemia and diffuse large B-cell lymphoma.Semantic proximity Read ↗

Chronic Lymphocytic Leukemia: Prognostic/Predictive Factors in the Era of Novel DrugsSemantic proximity Read ↗

Prognostication in chronic lymphocytic leukemia.Semantic proximity Read ↗

Biomarkers in chronic lymphocytic leukemia: Clinical applications and prognostic markersSemantic proximity Read ↗

Implications of new prognostic markers in chronic lymphocytic leukemia.Semantic proximity Read ↗

Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary Era.Semantic proximity Read ↗

Implications of new prognostic markers in chronic lymphocytic leukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.